🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Cytosorbents Corporation (CTSO)
NASDAQ: CTSO · Real-Time Price · USD
5.13
-0.44 (-7.82%)
At close: Nov 19, 2026, 4:00 PM EST
5.15
+0.02 (0.39%)
After-hours: Nov 19, 2026, 4:36 PM EST

Cytosorbents Stock Forecast

CTSO's stock price has decreased by -58.73% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

According to 2 analysts polled by S&P Global, Cytosorbents stock has an average price target of $32.5. The average 1-year stock price forecast is 533.53% higher than the current stock price, while the lowest is $15 (+192.40%) and the highest is $50 (+874.66%).

Price Target: $32.5 (+533.53%)
Analyst Consensus: n/a

Price Target

Chart
TargetLowAverageMedianHigh
Price$15$32.5$32.5$50
Change+192.40%+533.53%+533.53%+874.66%

Analyst Ratings

According to 1 stock analyst, the rating for Cytosorbents is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.

Recommendation Trends

RatingMar '26Apr '26May '26Aug '26Sep '26Nov '26
Strong Buy110000
Buy000000
Hold111111
Sell000000
Strong Sell000000
Total221111

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
WBB Securities
WBB Securities
Buy
Initiates
$9.5
BuyInitiates$9.5+85.19%Oct 21, 2026
H.C. Wainwright
H.C. Wainwright
Hold
Maintains
$15
HoldMaintains$15+192.40%Aug 7, 2026

Financial Forecast

Revenue This Year
37.86M
from 37.06M
Increased by 2.14%
Revenue Next Year
44.00M
from 37.86M
Increased by 16.24%
EPS This Year
0.40
EPS Next Year
-0.40
from 0.40
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
43.17M34.69M31.08M35.60M37.06M37.86M
Revenue Growth
5.27%-19.64%-10.39%14.51%4.12%2.14%
Gross Profit
32.12M20.73M21.95M24.89M26.49M27.71M
Gross Margin
74.41%59.77%70.62%69.92%71.48%73.20%
Operating Income
-22.74M-30.89M-31.95M-16.45M-14.24M-8.20M
Net Income
-24.56M-32.81M-29.25M-20.72M-8.20M-11.68M
EPS
-----0.40
Forward PE
-----12.83
Free Cash Flow
------12.02M
No. Analysts
-----1
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High37.9M
Avg37.9M
Low37.9M

Revenue Growth

Revenue Growth202620272028
High
2.1%
Avg
2.1%
Low
2.1%

EPS Forecast

EPS202620272028
High0.40
Avg0.40
Low0.40

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-